Concepedia

Tapentadol in cancer pain management: a prospective open-label study

Sebastiano Mercadante, Giampiero Porzio, Patrizia Ferrera, Federica Aielli, Claudio Adile, Corrado Ficorella, Alessandra Casuccio

Current Medical Research and Opinion · 2012 · 65 citations · 16 references

DOIFull text

Open access

Abstract

This was an open-label study for exploratory purposes. Data should be confirmed in controlled studies with a larger number of patients.

References

16

pain<i>DETECT</i>: a new screening questionnaire to identify neuropathic components in patients with back pain

Rainer Freynhagen, Ralf Baron, Ulrich Gockel et al. · Current Medical Research and Opinion · 2006 · 2.2K citations

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

Sherwyn Schwartz, Mila Etropolski, Douglas Y. Shapiro et al. · Current Medical Research and Opinion · 2010 · 256 citations

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

Robert Buynak, Douglas Y. Shapiro, Akiko Okamoto et al. · Expert Opinion on Pharmacotherapy · 2010 · 250 citations

Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

Marc Afilalo, Mila Etropolski, Brigitte Kuperwasser et al. · Clinical Drug Investigation · 2010 · 226 citations

, , +10

Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain

James Wild, Stefan Grond, Brigitte Kuperwasser et al. · Pain Practice · 2010 · 181 citations